Pharma Journalist - Page 700 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Concept Life Sciences expands GXP compliance

Novo Nordisk Launches Rebinyn in the United States for People with Hemophilia B

Sosei Provides an Update on Its Immuno-Oncology Clinical Program with AstraZeneca

Selvita appoints Steffen Heeger as Chief Medical Officer

Major research project launched to crack aspirin’s anti-cancer properties

Roivant Sciences and ArQule enter into License Agreement for Derazantinib in China

Xcovery initiates Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations

Capricor receives FDA RMAT Designation for Duchenne Muscular Dystrophy Therapy

FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials